Overbrook Management Corp’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,000
| Closed | -$590K | – | 70 |
|
|
2023
Q2 | $590K | Hold |
15,000
| – | – | 0.14% | 40 |
|
|
2023
Q1 | $365K | Hold |
15,000
| – | – | 0.1% | 56 |
|
|
2022
Q4 | $321K | Hold |
15,000
| – | – | 0.09% | 60 |
|
|
2022
Q3 | $269K | Hold |
15,000
| – | – | 0.08% | 64 |
|
|
2022
Q2 | $144K | Hold |
15,000
| – | – | 0.04% | 83 |
|
|
2022
Q1 | $252K | Hold |
15,000
| – | – | 0.06% | 83 |
|
|
2021
Q4 | $251K | Hold |
15,000
| – | – | 0.05% | 89 |
|
|
2021
Q3 | $244K | Buy |
+15,000
| New | +$163K | 0.05% | 78 |
|
|
2016
Q4 | – | Sell |
-33,152
| Closed | -$1.53M | – | 81 |
|
|
2016
Q3 | $1.53M | Sell |
33,152
-42,500
| -56% | -$2.4M | 0.35% | 40 |
|
|
2016
Q2 | $3.86M | Sell |
75,652
-36,477
| -33% | -$1.81M | 0.81% | 29 |
|
|
2016
Q1 | $4.74M | Sell |
112,129
-5,678
| -5% | -$289K | 1.02% | 23 |
|
|
2015
Q4 | $9.25M | Hold |
117,807
| – | – | 1.61% | 18 |
|
|
2015
Q3 | $4.77M | Buy |
117,807
+123
| +0.1% | +$6.52K | 0.74% | 26 |
|
|
2015
Q2 | $6.13M | Buy |
117,684
+67,684
| +135% | +$3.37M | 0.93% | 22 |
|
|
2015
Q1 | $2.33M | Buy |
+50,000
| New | +$2.6M | 0.38% | 39 |
|
Overbrook Management Corp's ISEE Position: Q3 2023 in Review
Overbrook Management Corp sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 15,000 shares — an estimated $590K sold.
Overbrook Management Corp first reported a position in ISEE in Q1 2015 and held it in 15 quarters. The position peaked at $9.25M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Overbrook Management Corp reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Overbrook Management Corp sold 15,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $590K.
- Overbrook Management Corp first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 15 quarters.
- Overbrook Management Corp's IVERIC bio, Inc. Common Stock position peaked at $9.25M in Q4 2015.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Overbrook Management Corp's 13F filing for Q3 2023, filed 13 Nov 2023.